Status: current, Defined. Date: 28-Feb 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1784321000168112 | Boostrix (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection suspension, 1 x 0.5 mL vial (trade product pack) | en | Fully specified name | Inactive | Case sensitive | Australian Medicines Terminology module |
| 1784331000168110 | Boostrix injection suspension, 0.5 mL vial | en | Synonym | Inactive | Case sensitive | Australian Medicines Terminology module |
| 3110591000168113 | Boostrix (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection, 1 x 0.5 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3110601000168118 | Boostrix injection, 0.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Boostrix (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection, 1 x 0.5 mL vial (trade product pack) | Is a | trade product pack | true | Inferred relationship | Some | ||
| Boostrix (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection, 1 x 0.5 mL vial (trade product pack) | Is a | diphtheria + tetanus + pertussis 3 component adolescent/adult vaccine injection, 0.5 mL vial | true | Inferred relationship | Some | ||
| Boostrix (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection, 1 x 0.5 mL vial (trade product pack) | has TPUU | Boostrix injection, 0.5 mL vial | true | Inferred relationship | Some | 1 | |
| Boostrix (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection, 1 x 0.5 mL vial (trade product pack) | has TP | Boostrix | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Boostrix injection, 0.5 mL vial | Is a | True | Boostrix (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + tetanus toxoid 20 international units) injection, 1 x 0.5 mL vial (trade product pack) | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Trade product pack reference set
FHIR